These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3447438)

  • 1. Isolation of sialylcompounds from hemofiltrate of chronic uremic patients and identification by nuclear magnetic resonance.
    Weisshaar G; Brunner H; Friebolin H; Baumann W; Mann H; Opferkuch HJ; Sieberth HG
    Adv Exp Med Biol; 1987; 223():219-22. PubMed ID: 3447438
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hydrophobic uremic middle molecules in hemofiltrate of a dialysis patient].
    Konobu K; Matsumoto T; Sawanishi K
    Nihon Jinzo Gakkai Shi; 1988 Feb; 30(2):151-60. PubMed ID: 3386019
    [No Abstract]   [Full Text] [Related]  

  • 3. Preparative isolation of middle molecular weight fractions from the hemofiltrate of patients with chronic uremia.
    Brunner H; Mann H; Essers U; Schultheis R; Byrne T; Heintz R
    Artif Organs; 1978 Nov; 2(4):375-7. PubMed ID: 743009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of two uremic toxins by nuclear magnetic resonance and mass spectrometry.
    Monti JP; Gallice P; Braguer D; Durand C; Murisasco A; Crevat A
    Adv Exp Med Biol; 1987; 223():223-6. PubMed ID: 3447439
    [No Abstract]   [Full Text] [Related]  

  • 5. Uremic toxins.
    Ringoir S; Schoots A; Vanholder R
    Kidney Int Suppl; 1988 Mar; 24():S4-9. PubMed ID: 3283412
    [No Abstract]   [Full Text] [Related]  

  • 6. Uremic middle molecules: analytical study of middle molecular weight fractions subpeak b4-2.
    Le Moel G; Strecker G; Cueille G; Boudet J; Man NK; Galli A; Agneray J
    Artif Organs; 1981; 4 Suppl():17-21. PubMed ID: 7295087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A compound from uremic plasma and from normal urine isolated by liquid chromatography and identified by nuclear magnetic resonance.
    Gallice P; Monti JP; Crevat A; Durand C; Murisasco A
    Clin Chem; 1985 Jan; 31(1):30-4. PubMed ID: 3965216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of unusually composed sialyl-compounds from hemofiltrate.
    Brunner H; Weisshaar G; Friebolin H; Baumann W; Mann H; Sieberth HG; Opferkuch HJ
    Int J Artif Organs; 1989 Dec; 12(12):755-61. PubMed ID: 2613356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and identification of canine plasma components suspected as uremic toxins.
    Kawamura M; Ohashi F; Nagata Y; Takai N; Motoie H; Nishimura R; Sasaki N; Takeuchi A
    J Vet Med Sci; 1993 Apr; 55(2):265-70. PubMed ID: 8513007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sialic acid containing compounds in the hemofiltrate of patients with chronic renal insufficiency. II. Isolation and structure determination of sialoglycopeptides].
    Weisshaar G; Baumann W; Friebolin H; Brunner H; Mann H; Sieberth HG; Opferkuch HJ
    Biol Chem Hoppe Seyler; 1987 Dec; 368(12):1545-58. PubMed ID: 3442598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of chromatographic fractions of blood ultrafiltrates of patients with chronic uremia on the fibrinolytic activity]].
    Popławski A; Myśliwiec M; Soszka J
    Pol Tyg Lek; 1990 Oct 1-8; 45(40-41):810-3. PubMed ID: 2096374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino acid composition of uremic middle and low molecular weight retention products.
    Bazilinski N; Shaykh M; Ahmed S; Musiala T; Williams RH; Poulos A; Dubin A; Dunea G
    Adv Exp Med Biol; 1987; 223():197-204. PubMed ID: 3447436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane and chromatography separation techniques for the preparative isolation of uremic toxins.
    Brunner H; Mann H
    Life Support Syst; 1983; 1 Suppl 1():199-206. PubMed ID: 6336410
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemofiltration-induced serum modifications in the pattern of larger molecules.
    David S; Barani R; Buzio C; Arisi L; Quaretti P
    Adv Exp Med Biol; 1987; 223():281-6. PubMed ID: 3447447
    [No Abstract]   [Full Text] [Related]  

  • 15. Uremic toxins and the elusive middle molecules.
    Schoots A; Mikkers F; Cramers C; de Smet R; Ringoir S
    Nephron; 1984; 38(1):1-8. PubMed ID: 6472528
    [No Abstract]   [Full Text] [Related]  

  • 16. Removal of uremic toxins and regeneration of hemofiltrate by a selective dual hemofiltration artificial kidney (SEDUFARK) system.
    Jørstad S; Smeby LC; Widerøe TE; Berg KJ
    Clin Nephrol; 1980 Feb; 13(2):85-92. PubMed ID: 6988123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of small peptide in uremic serum by high-performance liquid chromatography.
    Mabuchi H; Nakahashi H
    J Chromatogr; 1982 Mar; 228():292-7. PubMed ID: 7076752
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fluorescent component found in uremic middle-molecules in the hemofiltrate of a dialysis patient].
    Konobu K; Matsumoto T; Sawanishi K
    Nihon Jinzo Gakkai Shi; 1988 Feb; 30(2):161-7. PubMed ID: 3386020
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemical analytic approaches to the definition of uremic toxins.
    Furst P; Bergstrom J; Gordon A; Zimmermann L
    Ateneo Parmense Acta Biomed; 1975; 46(5):307-16. PubMed ID: 1232992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ascorbic acid derivatives in two different fractions of uremic toxins.
    Gallice PM; Monti JP; Braguer DL; Baz M; Elsen RE; Berland YF; Crevat AD
    Int J Artif Organs; 1991 Dec; 14(12):754-8. PubMed ID: 1783448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.